CIK: 1848717 - Address: C/O Revance Therapeutics, Inc, 1222 Demonbreun Street, 20Th Floor, Nashville, TN 37203
2 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/20/23 16:25
6/15/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKolaja Carey OconnorTNDM.d4518.12031817D
6/20/23 16:25
6/15/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKolaja Carey OconnorTNDS.d-7128.240-3-1317D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact